In November 2023, China agreed to restart cooperation with U.S. authorities to counter the flow of fentanyl and other synthetic opioids and their precursors into the United States. This refound willingness comes after more than two years of China purposefully denying cooperation and failing to mount adequate internal enforcement. China's strategic goal to stabilize the U.S.-China relationship was a crucial motivation, but U.S. diplomacy and actions also played an important role in bringing China back to cooperation. What remains to be seen in 2024 is how robust that anti-drug cooperation will be.
Authors
- Published in
- United States of America
